Concentrix Corporation (CNXC)
NASDAQ: CNXC · Real-Time Price · USD
32.28
+2.18 (7.24%)
Sep 1, 2026, 4:00 PM EDT - Market closed
Concentrix Income Statement
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
| 9,999 | 9,826 | 9,619 | 7,115 | 6,324 | 5,587 | |
Revenue Growth | 3.89% | 2.15% | 35.20% | 12.50% | 13.20% | 18.38% |
Cost of Revenue | 6,552 | 6,391 | 6,170 | 4,537 | 4,067 | 3,618 |
Gross Profit | 3,447 | 3,435 | 3,449 | 2,578 | 2,257 | 1,969 |
Selling, General & Admin | 2,401 | 2,395 | 2,401 | 1,706 | 1,423 | 1,415 |
Amortization of Goodwill & Intangibles | 425.07 | 434.33 | 458.93 | 214.83 | 162.67 | - |
Operating Expenses | 2,826 | 2,830 | 2,860 | 1,921 | 1,586 | 1,415 |
Operating Income | 620.74 | 605.27 | 589.32 | 656.94 | 671.55 | 554.75 |
Interest Expense | -279.07 | -290.35 | -321.83 | -201 | -70.08 | -23.05 |
Currency Exchange Gain (Loss) | 41.36 | 6.43 | 9.94 | -27.64 | -57.98 | -2.88 |
Other Non Operating Income (Expenses) | 19.97 | 22.2 | -7.43 | -20.07 | 95.28 | 14.5 |
EBT Excluding Unusual Items | 403 | 343.55 | 270.01 | 408.23 | 638.77 | 543.32 |
Merger & Restructuring Charges | -108.21 | - | - | - | -33.76 | -0.83 |
Impairment of Goodwill | -1,523 | -1,523 | - | - | - | - |
Gain (Loss) on Sale of Assets | -6.89 | - | - | - | - | 13.2 |
Asset Writedown | -4.46 | -4.46 | - | - | - | - |
Other Unusual Items | 3.3 | 1.96 | 29.27 | - | - | - |
Pretax Income | -1,237 | -1,182 | 299.27 | 408.23 | 605 | 555.7 |
Income Tax Expense | 77.88 | 96.7 | 48.06 | 94.39 | 169.36 | 150.12 |
Earnings From Continuing Operations | -1,314 | -1,279 | 251.22 | 313.84 | 435.64 | 405.58 |
Minority Interest in Earnings | - | - | - | - | -0.59 | - |
Net Income | -1,314 | -1,279 | 251.22 | 313.84 | 435.05 | 405.58 |
Preferred Dividends & Other Adjustments | 2.52 | 4.1 | 9.5 | 6 | 6.63 | 5.79 |
Net Income to Common | -1,317 | -1,283 | 241.71 | 307.84 | 428.42 | 399.79 |
Net Income Growth | - | - | -21.48% | -28.14% | 7.16% | 142.58% |
Shares Outstanding (Basic) | 62 | 63 | 65 | 54 | 51 | 51 |
Shares Outstanding (Diluted) | 62 | 63 | 65 | 54 | 52 | 52 |
Shares Change | -3.83% | -3.17% | 20.48% | 4.39% | -0.34% | 0.60% |
EPS (Basic) | -21.35 | -20.36 | 3.72 | 5.72 | 8.34 | 7.78 |
EPS (Diluted) | -21.35 | -20.36 | 3.71 | 5.70 | 8.28 | 7.70 |
EPS Growth | - | - | -34.83% | -31.17% | 7.52% | 141.45% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Free Cash Flow | 513.53 | 572.47 | 428.73 | 497.48 | 460.7 | 365.1 |
Free Cash Flow Per Share | 8.32 | 9.09 | 6.59 | 9.21 | 8.90 | 7.03 |
Dividend Per Share | 1.413 | 1.358 | 1.240 | 1.127 | 1.025 | 0.250 |
Dividend Growth | 8.61% | 9.51% | 10.00% | 10.00% | 310.00% | - |
Gross Margin | 34.47% | 34.96% | 35.85% | 36.23% | 35.69% | 35.25% |
Operating Margin | 6.21% | 6.16% | 6.13% | 9.23% | 10.62% | 9.93% |
Profit Margin | -13.17% | -13.06% | 2.51% | 4.33% | 6.77% | 7.16% |
Free Cash Flow Margin | 5.14% | 5.83% | 4.46% | 6.99% | 7.28% | 6.54% |
EBITDA | 1,275 | 1,266 | 1,295 | 1,045 | 981.09 | 831.92 |
EBITDA Margin | 12.75% | 12.88% | 13.46% | 14.69% | 15.51% | 14.89% |
D&A For EBITDA | 653.9 | 660.43 | 705.85 | 388.3 | 309.54 | 277.18 |
EBIT | 620.74 | 605.27 | 589.32 | 656.94 | 671.55 | 554.75 |
EBIT Margin | 6.21% | 6.16% | 6.13% | 9.23% | 10.62% | 9.93% |
Effective Tax Rate | - | - | 16.06% | 23.12% | 27.99% | 27.02% |